Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming June 25, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors ...
WATE 6 On Your Side

Akero Therapeutics (AKRO) Slides After Failed Trial, Hit With Class Action Lawsuit – Hagens Berman

Akero Therapeutics, Inc. (AKRO) Securities Fraud Class Action: Akero Therapeutics, a biopharmaceutical company developing treatments for liver disease, is facing a securities class action lawsuit over ...
Business Insider

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Akero Therapeutics, Inc. (AKRO)

Philadelphia, Pennsylvania--(Newsfile Corp. - June 26, 2024) - Grabar Law Office is investigating whether officers and directors of Akero Therapeutics, Inc. (NASDAQ: AKRO) breached their fiduciary ...
Morningstar

AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

(1) that approximately 20% of the patients enrolled in Akero’s 96-week SYMMETRY study had cryptogenic cirrhosis and did not have definitive NASH at baseline (a nonalcoholic fatty liver disease ...